PFM Health Sciences’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,785
Closed -$3.19M 94
2022
Q4
$3.19M Buy
+15,785
New +$3.09M 0.11% 76
2021
Q3
Sell
-74,077
Closed -$17.6M 95
2021
Q2
$17.6M Buy
+74,077
New +$16.9M 0.55% 52
2021
Q1
Sell
-149,108
Closed -$26.1M 101
2020
Q4
$26.1M Sell
149,108
-17,720
-11% -$3.06M 0.92% 43
2020
Q3
$27M Sell
166,828
-194,396
-54% -$30.8M 1.25% 30
2020
Q2
$51.5M Buy
+361,224
New +$50M 2.67% 8

Other funds holding LH

PFM Health Sciences's LH Position: Q1 2023 in Review

PFM Health Sciences sold out of Labcorp (LH) in Q1 2023, closing a stake of 15,785 shares — an estimated $3.19M sold.

PFM Health Sciences first reported a position in LH in Q2 2020 and held it in 5 quarters. The position peaked at $51.5M in Q2 2020. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • PFM Health Sciences reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • PFM Health Sciences sold 15,785 Labcorp shares in Q1 2023, an estimated $3.19M.
  • PFM Health Sciences first reported a position in Labcorp in Q2 2020 and held it in 5 quarters.
  • PFM Health Sciences's Labcorp position peaked at $51.5M in Q2 2020.
  • 940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on PFM Health Sciences's 13F filing for Q1 2023, filed 15 May 2023.